MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 152 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $87,000 | -26.9% | 1,213 | 0.0% | 0.02% | -8.7% |
Q1 2022 | $119,000 | +15.5% | 1,213 | 0.0% | 0.02% | +27.8% |
Q4 2021 | $103,000 | 0.0% | 1,213 | -6.0% | 0.02% | 0.0% |
Q3 2021 | $103,000 | -18.3% | 1,291 | 0.0% | 0.02% | -10.0% |
Q2 2021 | $126,000 | -16.6% | 1,291 | 0.0% | 0.02% | -23.1% |
Q1 2021 | $151,000 | +4.9% | 1,291 | 0.0% | 0.03% | +4.0% |
Q4 2020 | $144,000 | -5.9% | 1,291 | 0.0% | 0.02% | -13.8% |
Q3 2020 | $153,000 | +4.8% | 1,291 | 0.0% | 0.03% | +11.5% |
Q2 2020 | $146,000 | +69.8% | 1,291 | 0.0% | 0.03% | +36.8% |
Q1 2020 | $86,000 | -27.1% | 1,291 | 0.0% | 0.02% | -13.6% |
Q4 2019 | $118,000 | +6.3% | 1,291 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $111,000 | +58.6% | 1,291 | +93.8% | 0.02% | +69.2% |
Q2 2019 | $70,000 | -15.7% | 666 | 0.0% | 0.01% | -13.3% |
Q1 2019 | $83,000 | +10.7% | 666 | 0.0% | 0.02% | 0.0% |
Q4 2018 | $75,000 | -47.6% | 666 | 0.0% | 0.02% | -16.7% |
Q3 2018 | $143,000 | +5.9% | 666 | +38.5% | 0.02% | +5.9% |
Q2 2018 | $135,000 | – | 481 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |